Millions of women worldwide are unable to access cervical cancer screening.
Cervical cancer is a major cause of morbidity and mortality worldwide.
TruScreen has been clinically tested by over 40,000 women around the world.
Better access to cervical cancer screening will save thousands of lives.
TruScreen supports cervical screening in remote areas and developing countries.
TruScreen performs equal to, or better than, alternative cervical screening tool